Fig. 2. Percentage (%) of days without heartburn and/or acid regurgitation in non-erosive reflux disease subjects; dexlansoprazole 30 mg (n = 207). For each parameter, the percentage of days ranged from 0 to 100.

Journal of Neurogastroenterology and Motility 2020;26:85~95 https://doi.org/10.5056/jnm19031

© J Neurogastroenterol Motil